Invegrow Paves Malawi’s Path to Hempcrete Housing: ‘Building Differently, Building for Africa’
Malawi’s leading cannabis company, Invegrow, is building its own offices out of hempcrete. This is part of the company’s drive to find low cost hemp solutions for housing under the theme: Building Differently, Building for Africa’.
African Policy-makers Largely Blind to the Transformative Potential of Hemp
A dedicated focus on industrial hemp could be transformative for Africa, but only 12 of the continent’s 54 countries have grasped its potential. Africa editor John Makoni writes that the plant is there, ready and waiting, he wonders why policy-makers are so slow to come to the party.
Danger that 2026 Could Be Another Wasted Year as Cannabis Reform Momentum Shows Signs of Fragmenting
This year started with renewed government energy on the cannabis reform front, but the challenge of aligning policy between different departments is proving difficult. The DTIC is now beginning to miss its own deadlines with the net effect that a new Cannabis law is unlikely to be passed before 2028.
Clash of the Titans: Bob Marley Estate Sues Tilray for Royalties-Related Fraud
Bob Marley’s estate has accused cannabis multinational Tilray Brands of fraud by deliberately hiding royalties payments due to the commercial heirs of the legendary reggae icon. The estate has filed a lawsuit to recover US$11 million it believes it is due.
SA Medical Journal: ‘Dual Use’ Nicotine and Cannabis Vaping Becoming a Schools Health Issue
Vaping has replaced cigarettes as the dominant inhalant amongst adolescents. This is one of the findings of a new study published in the SAMJ which warns that ‘dual use’ vaping with nicotine and cannabis is a growing public health crisis facing South African schools
Thailand: Mass Cannabis Retail Closure as Model Shifts to ‘Medical Only’
Thailand’s move away from general adult-use towards a ‘medical only’ model has led to the decimation of that country’s ‘Grey Zone’. Of the 18 000 cannabis outlets facing closure, fewer than 15% are likely to continue under new regulations which specify that cannabis sales are for medical use only.
Trump Opens the Door for Psychedelic Drugs to Treat Serious Mental Illness
President Donald Trump has opened the door for psychedelic drugs to be used as a potential treatment for serious mental illness. He signed an executive order on 18 April 2026 that empowers the FDA to do this and put aside US$50 million for psychedelics research.
The Big Cannabis Issue Facing the World: Who Benefits from Legalization and Who Gets Left Behind?
International collaboration is one of the pathways for marginalized cannabis communities to have their voices heard. Soweto Cannabis Association founder Tia Ramfate (pictured here) is to visit Canada to strengthen international ties for the AfuRaka Foundation she has launched.
Ninth Wave’s Campher: Cannabis ‘Grey Zone Regulation will Lead to Demand for Marketing and Sales Jobs
As the cannabis retail ‘Grey Zone’ becomes regulated there will be a growing demand for sales and marketing skills sets within the sector. Ninth Wave recruitment specialist Lourie Campher (pictured here) says cultivation and pharmaceutical specialists are currently in demand, but the job pool is steadily expanding into other disciplines.
Lesotho Rising: New Markets Await as MG Health and LuCan Labs Awarded EU GMP Certification
Lesotho’s cannabis revival has been given a huge boost with independent EU-GMPCertification awarded to MG Health and LuCan Labs late last year. MG Health founder Andre Bothma, says the recognition is a major step forward in the company’s global cannabis strategy that will benefit the country as a whole.